<DOC>
	<DOCNO>NCT02793700</DOCNO>
	<brief_summary>Respiratory distress syndrome ( RDS ) life-threatening condition premature neonate . Antenatal glucocorticoid use clinically woman threaten preterm birth accelerate lung maturation 40 year . The current treatment strategy woman threaten preterm delivery standard , `` one size fit '' dose either betamethasone ( BMZ ) dexamethasone . It well known pregnancy introduces additional variability response medication therapy different physiological change alteration activity drug metabolize enzyme . The objective project evaluate pharmacokinetic ( PK ) , pharmacodynamic , pharmacogenetic parameter betamethasone ( BMZ ) determine difference response benefit pregnancy . An individualized dosing approach medication pregnancy , BMZ , crucial optimize efficacy important medication .</brief_summary>
	<brief_title>Pharmacokinetics ( PK ) Modeling Betamethasone Therapy Threatened Preterm Birth</brief_title>
	<detailed_description>After consent , maternal sample whole blood obtain DNA isolation . Investigators collect plasma sample 4 time point participant . These do baseline ( pre-dose ) , 0.5-2 hour , 4-6 hour , 22-24 hour first dose BMZ administer . Investigators obtain serum estriol measurement participant within 2 hour antenatal corticosteroid administration 24 hour dose give ( betamethasone administer 2 dos 24 hour apart ) . Investigators obtain saliva sample measurement estriol time . Participants offer optional participation detail PK portion study . Participants consent part study additional plasma sample obtain schedule sample approximately 10-15 hour first dose 6-8 hour , 24 , 48 hour 2nd dose . One sample collect time . At time delivery , umbilical cord blood collect discarded DNA , serum plasma . Four placenta section collect . A maternal blood sample also obtain serum plasma . If investigator unable obtain umbilical cord blood , buccal swab collect baby DNA extraction . A chart review do infant within 30 day birth review record neonatal outcome .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<criteria>Gestational age 2334 week diagnosis threaten preterm labor preterm premature rupture membrane , diagnosis high likelihood preterm delivery provider recommend administer antenatal corticosteroid Singleton gestation Live fetus time enrollment Being administer antenatal corticosteroid enhance lung maturity Ability provide write informed consent participate study Maternal age &lt; 18 year old Major congenital anomaly Known severe abruptio placenta time enrollment Multiple gestation Hepatic failure ( history hepatic failure , cirrhosis 2 fold increase Aspartate Aminotransferase ( AST ) Alanine Aminotransferase ( ALT ) Renal failure ( serum creatinine &gt; 2 mg/dl )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Betamethasone</keyword>
</DOC>